Cite

    Silvestris, N. et al. (n.d.). Basal and bevacizumab-based therapy-induced changes of lactate dehydrogenases and fibrinogen levels and clinical outcome of previously untreated metastatic colorectal cancer patients: a multicentric retrospective analysis. Expert opinion on biological therapy. pp. 155-162. [Online].